Literature DB >> 8166529

High-frequency jet versus conventional ventilation in infants undergoing Blalock-Taussig shunts.

D A Davis1, P A Russo, J S Greenspan, G Speziali, A Spitzer.   

Abstract

Nine infants undergoing modified Blalock-Taussig shunts were randomized to both high-frequency jet ventilation (HFJV) and conventional ventilation (CV). Vital signs, blood gases, mean airway pressure, lung mechanics, functional residual capacity, and lung movement were compared on both modes of ventilation keeping peak inspiratory and expiratory pressures constant. The mean airway pressure was lower on HFJV than on CV (8.5 versus 10.9 cm H2O). Arterial partial pressure of oxygen was greater on HFJV than on CV (55 versus 46 mm Hg), arterial partial pressure of carbon dioxide was lower on HFJV than on CV (28 versus 37 mm Hg), whereas compliance (0.54 versus 0.56 mL.cm H2O-1.kg-1). resistance (110 versus 95 cm H2O/L.s), and functional residual capacity (23 versus 22.5 mL/kg) remained the same. Lung movement and degree of retraction necessary for surgical exposure as evaluated by an independent observer was less with HFJV compared with CV. Compared with CV during the creation of Blalock-Taussig shunts, HFJV provides better gas exchange at lower mean airway pressure with similar lung function, lung volume, and hemodynamics.

Entities:  

Mesh:

Year:  1994        PMID: 8166529     DOI: 10.1016/0003-4975(94)90187-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Navigated Percutaneous Lung Ablation under High-Frequency Jet Ventilation of a Metastasis from a Wilms' Tumour: A Paediatric Case Report.

Authors:  Jacob Freedman; Piotr Harbut
Journal:  Case Rep Oncol       Date:  2016-07-29

2.  Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC).

Authors:  Martin C J Kneyber; Daniele de Luca; Edoardo Calderini; Pierre-Henri Jarreau; Etienne Javouhey; Jesus Lopez-Herce; Jürg Hammer; Duncan Macrae; Dick G Markhorst; Alberto Medina; Marti Pons-Odena; Fabrizio Racca; Gerhard Wolf; Paolo Biban; Joe Brierley; Peter C Rimensberger
Journal:  Intensive Care Med       Date:  2017-09-22       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.